Skip to main content
Clinical Trials/NCT05455047
NCT05455047
Completed
Not Applicable

Study of Metabolic Connectivity in Drug-resistant Temporal Epilepsy

Central Hospital, Nancy, France1 site in 1 country90 target enrollmentFebruary 1, 2022
ConditionsEpilepsy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Epilepsy
Sponsor
Central Hospital, Nancy, France
Enrollment
90
Locations
1
Primary Endpoint
Metabolic connectivity
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

18F-Fluoro-deoxy-glucose (18F-FDG) positron emission tomography (PET) has a high sensitivity for temporal lobe epilepsy (TLE), the most common form of focal epilepsy, with a detection range of 86-90% . Therefore, 18F-FDG PET is a useful tool to identify the epileptogenic zone (ETZ) in the inter-ictal phase of drug-resistant temporal epilepsy during pre-surgical evaluation . Based on stereotactic electroencephalography (SEEG) findings, a correspondence between electrical data and metabolic changes on PET was found at the group level by identifying four different patterns of TLE . As expected, hypometabolism was not limited to the EZ defined by SEEG, but underlay broader epileptic networks . Because of the different electroclinical presentations of TLE, 18F-FDG PET appears to be a very useful tool in these temporal epilepsies. Indeed, it has been recently demonstrated that a gradient of PET hypometabolism from the uninvolved area to the spreading area, then to the epileptogenic area and to the lesion area is observed with consequently a good performance of 18F-FDG PET in defining the EZ .

Therefore, it is interesting to study PET metabolism as a network and not as a combination of regional metabolic measures in epilepsy.

Registry
clinicaltrials.gov
Start Date
February 1, 2022
End Date
June 1, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Central Hospital, Nancy, France
Responsible Party
Principal Investigator
Principal Investigator

Antoine VERGER

MD, PhD

Central Hospital, Nancy, France

Eligibility Criteria

Inclusion Criteria

  • Patients with drug-resistant temporal epilepsy with an accurate diagnosis on SEEG
  • Patients with epilepsy who have had a PET/CT scan with 18F-FDG as part of a pre-operative assessment
  • Person having received complete information on the organization of the research and not having objected to the use of these data;
  • Patients affiliated to a social security system

Exclusion Criteria

  • Person who has not received full information on the organization of the research and who has opposed the use of this data
  • A person of full age who is the subject of a legal protection measure (guardianship, curatorship, safeguard of justice).
  • A person of full age who is unable to give consent and who is not subject to a legal protection measure

Outcomes

Primary Outcomes

Metabolic connectivity

Time Frame: 1 month

Metabolic connectivity of hypometabolic clusters in each temporal epilepsy subgroup defined by IRCA (interregional correlation analysis) and graph theory

Study Sites (1)

Loading locations...

Similar Trials